The BioCanRx network is changing the face of cancer treatment


BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.

New Partnership Strengthens Biomanufacturing in Canada
Biomanufacturing in Canada has a bit of a “flavour of the month” feel to it, with its importance made vivid by Canada’s lack of ability to manufacture the vaccines that are so critical in fighting Covid-19.
Learn more →
A multi-target improvement for CAR T therapy
Llamas have served the people of the Andes mountains in South America for centuries. Today, llamas are also being put to work here in Canada, to help develop novel forms of antibodies that can then be used for CAR T therapy.
Learn more →
Where Are They Now: Hayley McKay
Hi, I’m Hayley. I grew up in Ottawa and have always been fascinated by biology and medicine.
Learn more →
Summit for Cancer Immunotherapy
summitforcancer Join us for our Summit Speaker Series virtual talks to hear the latest in immunotherapy research!

Summit4CI Speaker Series

Learn more about Summit4CI
Learning Institute Community Dissemination Report 2019
The participants of the 2019 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.

Click here for the full report
For the latest BioCanRx news and network activities:

Subscribe to our newsletter and email updates Subscribe
Follow us on Twitter
Like us on Facebook
Follow us on Instagram Follow
Subscribe to us on Youtube  Subscribe
Follow us on LinkedIn Follow
  Our Network Members